USPTO serial 74252869
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth B. Germain
KENNETH B GERMAIN FROST & JACOBS2500 CENTRAL TRUST CTR201 E FIFTH STCINCINNATI, OH 45202| Class | Description | Status | First use |
|---|---|---|---|
| 036 | property and casualty insurance underwriting services | ABANDONED | Jul 7, 1965 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 1994 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Feb 23, 1994 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Feb 23, 1994 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Aug 10, 1993 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 29, 1993 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| Jul 2, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 1993 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 27, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 26, 1992 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 1992 | DOCK | ASSIGNED TO EXAMINER | — |